Cyient DLM Stock: Analyst Upgrades to Buy, Sets ₹416 Target

BROKERAGE-REPORTS
Whalesbook Logo
AuthorAarav Shah|Published at:
Cyient DLM Stock: Analyst Upgrades to Buy, Sets ₹416 Target
Overview

Cyient DLM's Q3 revenue missed estimates, primarily due to a large order completion in the prior year. However, analysts are reiterating a 'Buy' rating, setting a revised target price of ₹416. They anticipate a gradual revenue recovery from Q4FY26, projecting robust growth in FY27 driven by a strong order book and expanding margins. Earnings are expected to compound significantly through FY28.

Q3 Performance and Segmental Breakdown

Cyient DLM reported a revenue of ₹303.30 crore for Q3 FY26, falling below expectations primarily because a large order concluded in the prior year's comparable quarter. Segment contributions showed mixed performance. Aerospace and defence, medical technology, and industrials accounted for 37%, 8%, 16%, and 30% respectively. While Aerospace and Industrials saw year-on-year growth of 14.8% and 57.6%, Defence and Medical Technology declined sharply by 88.1% and 39.3%.

The margin-accretive cables segment exhibited strong growth, up 36.6% year-on-year. Conversely, contributions from PCBA and box-build segments decreased to 51.0% and 25.8% respectively. These fluctuations highlight the diverse nature of Cyient DLM's service offerings and their varying market dynamics.

Analyst's Forward Outlook and Growth Projections

Despite the Q3 revenue miss, analysts project a gradual recovery in revenues starting from Q4 FY26. This optimism is underpinned by a robust order book and a healthy book-to-bill ratio. Management is also focused on executing deferred shipments, which is expected to boost near-term performance. Fiscal year 2027 is anticipated to be materially stronger than fiscal year 2026.

Analysts forecast that Cyient DLM will deliver consistent growth over the medium term. Expected revenue, EBITDA, and PAT to grow at compound annual growth rates of 10.6%, 13.7%, and 19.1%, respectively, between fiscal years 2025 and 2028. This sustained growth trajectory is a key factor driving the positive outlook.

Margin Expansion and Valuation

Margin improvements are also a central theme in the analyst report. Margins are expected to remain in double digits and trend higher. This is attributed to scaling volumes driving operating leverage, a structurally healthier product and industry mix, and the increasing contribution from Build-to-Service (B2S) programs. These factors are expected to enhance profitability.

Valuing the stock at a Price-to-Earnings (P/E) multiple of 26 times on FY28 estimated Earnings Per Share (EPS), analysts have maintained their 'Buy' rating. The revised target price is set at ₹416, reflecting improving earnings visibility and a strengthening margin profile. This target price suggests significant upside potential from current levels.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.